Efficacy and Safety of the Vasopressin V1A/V2-Receptor Antagonist Conivaptan in Acute Decompensated Heart Failure: A Dose-Ranging Pilot Study

Steven R. Goldsmith, Uri Elkayam, W. Herbert Haught, Abhijit Barve, Weizhong He

Research output: Contribution to journal › Article › peer-review

75 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and Safety of the Vasopressin V1A/V2-Receptor Antagonist Conivaptan in Acute Decompensated Heart Failure: A Dose-Ranging Pilot Study'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience